BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 17, 2001
View Archived Issues
Bakuchiol has in vitro antimicrobial activity against oral pathogens
Read More
Past exposure to vaccines may reduce risk of Alzheimer's disease
Read More
Transition Therapeutics acquires intellectual property to methyldonor technology for MS
Read More
Garlic supplements shown to interfere with HIV medication
Read More
Endovasc's NRA moves towards clinical development
Read More
Genaissance and AstraZeneca sign genomics agreement
Read More
Atugen and Oxford GlycoSciences collaborate on target validation
Read More
Genzyme and Pharming reach agreement
Read More
Discovery and Quintiles form Surfaxin sales and marketing alliance
Read More
Pexelizumab collaboration reviewed; 5G1.1 progress updated
Read More
Enrollment ahead of schedule in ISAtx-247 phase II psoriasis trial
Read More
Adolor receives three SBIR grants for pain relief research
Read More
Genaera identifies and targets novel gene in asthma
Read More
Antiangiogenic agent SU-6668/TSU-68 particularly effective against breast cancer
Read More
Mechanism of SAANDs confirmed in breast cancer cells
Read More
New therapeutic option available to leukemia patients in the U.K.
Read More
CDRI-93/478: preclinical compound for hypertension and myocardial ischemia
Read More
FR-226807, a highly potent and selective PDE5 inhibitor, compares favorably with sildenafil
Read More
TRAIL active against primary CLL and WSU-CLL alone and in combination with chemotherapeutic agents
Read More
New malaria vaccine offers significant protection against Plasmodium falciparum
Read More
First small-molecule cancer targets selected from BMS-Exelixis collaboration
Read More
Potent DP receptor antagonists claimed by Merck Frosst for allergic conditions
Read More
Roche spin-off company patents new triazole antifungal agents
Read More
Aminophenoxyacetamides with neuroprotective properties synthesized at Suntory
Read More
Inhibitors of NHE-3 designed by Merck KGaA
Read More
Preparation and use of nonpeptide MetAP2 inhibitors reported by GSK
Read More
Potent and selective inhibitors of thrombin disclosed by Corvas in recent patent
Read More
Distinctive endocrine profile of abarelix compared with LHRH agonists in prostate cancer
Read More